\-\ Texto\\:\\ \ \(0\)\
\-\ negative\ \(599\)\
\-\ tumor\\ resected\\.\\ \\ post\\-op\\ clinical\\ course\\ was\\ complicated\\ by\\ sepsis\\ and\\ by\\ a\\ large\\ left\\ pca\\ infarct\\.\ \(0\)\
\-\ complex\\ mass\\ occupying\\ the\\ frontal\\ horn\\ of\\ the\\ left\\ lateral\\ ventricle\\ with\\ minimal\\ patchy\\ enhancement\\.\ \(0\)\
\-\ subependymoma\\,\\ lateral\\ ventricle\ \(0\)\
\-\ \\â\\€\\¢\\ neurocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ subependymal\\ giant\\ cell\\ astrocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ pappilloma\ \(0\)\
\-\ \\â\\€\\¢\\ menintioma\ \(0\)\
\-\ 43\\ y\\.o\\.\\ man\\ with\\ headaches\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ menintioma\\:\\ 0\\.1469253070661083\ \(0\)\
\-\ pappilloma\\:\\ 0\\.13537285405677588\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1305845292996573\ \(0\)\
\-\ ventricle\\:\\ 0\\.10674634391928092\ \(0\)\
\-\ pca\\:\\ 0\\.10294101823918732\ \(0\)\
\-\ subependymoma\\:\\ 0\\.1007154950287786\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.09023868403840571\ \(0\)\
\-\ occupying\\:\\ 0\\.08865018104166696\ \(0\)\
\-\ sepsis\\:\\ 0\\.08766950604128473\ \(0\)\
\-\ subependymal\\:\\ 0\\.08503243928770317\ \(0\)\
\-\ post\\-op\\:\\ 0\\.08348093223660298\ \(0\)\
\-\ horn\\:\\ 0\\.07735218590118101\ \(0\)\
\-\ 43\\:\\ 0\\.07684709674292554\ \(0\)\
\-\ patchy\\:\\ 0\\.07635686532282064\ \(0\)\
\-\ complicated\\:\\ 0\\.07389152982154361\ \(0\)\
\-\ choroid\\:\\ 0\\.07268618546188317\ \(0\)\
\-\ resected\\:\\ 0\\.07050918242159876\ \(0\)\
\-\ plexus\\:\\ 0\\.06920132216424052\ \(0\)\
\-\ giant\\:\\ 0\\.0685839676362347\ \(0\)\
\-\ ependymoma\\:\\ 0\\.06375143061979603\ \(0\)\
\-\ infarct\\:\\ 0\\.0631939650520037\ \(0\)\
\-\ lateral\\:\\ 0\\.06155560152081834\ \(0\)\
\-\ complex\\:\\ 0\\.05703151462690228\ \(0\)\
\-\ minimal\\:\\ 0\\.05607466617334663\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.055305836644554934\ \(0\)\
\-\ headaches\\:\\ 0\\.05444070565118797\ \(0\)\
\-\ course\\:\\ 0\\.05374219072426069\ \(0\)\
\-\ by\\:\\ 0\\.04742903010816249\ \(0\)\
\-\ frontal\\:\\ 0\\.04473819890805596\ \(0\)\
\-\ clinical\\:\\ 0\\.04382183000110007\ \(0\)\
\-\ negative\\:\\ 0\\.04253533602291457\ \(0\)\
\-\ y\\.o\\:\\ 0\\.041106323876445\ \(0\)\
\-\ cell\\:\\ 0\\.038470678526358104\ \(0\)\
\-\ enhancement\\:\\ 0\\.038174812768717266\ \(0\)\
\-\ man\\:\\ 0\\.03368219738483332\ \(0\)\
\-\ tumor\\:\\ 0\\.03320387169351352\ \(0\)\
\-\ left\\:\\ 0\\.03187017564243049\ \(0\)\
\-\ large\\:\\ 0\\.031142373863851328\ \(0\)\
\-\ mass\\:\\ 0\\.019807683449126076\ \(0\)\
\-\ was\\:\\ 0\\.01647129203689478\ \(0\)\
\-\ a\\:\\ 0\\.006609996696976688\ \(0\)\
\-\ the\\:\\ 0\\.00460830949012086\ \(0\)\
\-\ \\,\\:\\ 0\\.004511834425288123\ \(0\)\
\-\ with\\:\\ 0\\.0039001392029963246\ \(0\)\
\-\ and\\:\\ 0\\.003000150095536974\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
\-\ of\\:\\ 0\\.0019417300132998072\ \(0\)\
